The brain imaging devices market size was valued at USD 5.68 billion in 2024 and is expected to reach USD 10.66 billion by 2032, growing at a CAGR of 8.21% over 2025-2032.
The brain imaging devices market trend is growing due to rising easier access & increasing incidence of neurological disorders, which include stroke, epilepsy, brain tumor, and other diseases, such as Alzheimer's. This increasing disease burden is leading to a greater need for early and non-invasive diagnostic assessment, such as MRI, CT, EEG, MEG, and PET, among others. Neuroimaging techniques are being upgraded in terms of AI application, the development of portable scanners, and that of multimodal systems, all of which will be ideal for raising the diagnostic accuracy rate and administrative level.
For instance, in March 2024, Cerca Magnetics and FieldLine Inc. commenced clinical trials of the wearable MEG systems, initiating the move away from bed-based systems to those that are real-time and ambulatory for brain monitoring.
Large companies including GE HealthCare, Siemens Healthineers, and Canon Medical are ramping up R&D spending for next-generation brain imaging technology. The rise of global healthcare and neurotechnologies investment, including public–private partnerships and programs, such as the NIH BRAIN Initiative, is strengthening innovation conduits. Furthermore, regulatory clearances by entities, including the FDA, for AI-based and wearables imaging solutions are fast-tracking market penetration. Growing availability of advanced imaging systems and expanding funding for diagnostic facilities also further reinforce the demand-supply equilibrium and reinforce the clinical adoption in medical institutions.
In April 2024, GE HealthCare unveiled an AI-enhanced MRI system optimized for brain diagnostics, which increases scan efficiency while cutting the procedure time by 40%.
Market Dynamics:
Drivers:
Surge in Neurological Disorder Diagnostics, Increased Funding in Neuroscience, and Technological Innovation in Imaging Tools Fuel Market Growth
Factors, such as a rise in diagnostics for neurological conditions, growth in neuroscience initiatives, and advancements in brain imaging, are the key drivers of the market. The World Health Organization (WHO) reports that more than 16% of global deaths are attributed to neurological diseases, reinforcing the pressing importance of reliable and rapid diagnosis. AI-powered imaging is making a rapid appearance. For instance, Philips debuted a deep-learning-enabled MRI in 2023 that allows for faster neuro scans with fewer artifacts.
On the investment side, brain-centered startup venture funding grew to over USD 1.2 billion globally over 2022-2024, indicating investors’ increasing confidence in the sector. In addition, public initiatives, such as the Canadian Brain Research Fund and China’s Brain Science and Brain-Inspired Intelligence Project, are growing pipelines of funding. This momentum has been supported by regulatory bodies, in which more than 30 neuroimaging devices were granted FDA 510(k) clearances between 2021-2024, which encouraged manufacturers to bring new products to market. This alignment of the demand for diagnostics, the flow of financing, and the right regulations in place will push the market along.
Restraints:
Brain Imaging Devices Market Faces Several Restraints, Particularly in Terms of Affordability, Infrastructure Gaps, and Workforce Limitations
High costs of capital for cutting-edge systems, such as PET-MRI hybrids, in excess of USD 2 million in many instances, make adoption challenging for smaller hospitals and outpatient clinic users. There is also a lack of skilled radiologists and neuroradiologists globally, leading to delayed active use of the state-of-the-art imaging equipment. Almost 28% of brain MRI facilities will be experiencing scan delays related to staffing deficits, according to a 2023 study from the American College of Radiology.
Regulatory barriers also present high barriers to entry, such as for MEG devices, which are subject to more rigorous review on account of EMF safety issues, resulting in longer approval cycles. Moreover, compatibility and data integration challenges with hospital PACS systems were impeding the smooth transition to a digital image environment. These supply-side and operating obstacles limit the scale of adoption of new technologies and hinder market take-up in less digitized health systems, in spite of high demand.
Segmentation Analysis:
By Product Type
The brain imaging devices market trend was the leading market in 2024 for imaging devices and represented an 82.5% share of the total. The ubiquity is derived from the crucial ability to diagnose a myriad of neurological disorders, including stroke, tumors, epilepsy, and traumatic brain injury, with modalities such as MRI, PET, CT, EEG, and MEG. These devices are being used increasingly in hospitals and imaging centers because of their high level of accuracy and clinical fidelity. Accessory type (electrode & sensor) is the fastest-growing. This power requirement is now increasing with the ever-increasing availability of portable and wearable neuroimaging devices, with applications in remote diagnostic and sleep studies. Brain imaging devices market growth momentum is also pegged by disposable accessory usage in ambulatory settings, wherein patient-centric & mobile healthcare gains center stage.
By Modality
In 2024, fixed brain imaging devices held a 64.8% share because of their wide application in clinical settings for highly detailed brain images in acute conditions, such as stroke and tumor. Their capacity for high-resolution whole-body imaging renders them invaluable in hospital-based neurology. Contrarily, wearable brain imaging devices were the fastest growing modality, which were primarily popularized due to the growing implementation of portable EEG and fNIRS devices for long-term recordings, studies of cognition, and decentralized trials. They are increasingly being used in outpatient and research settings for real-time analysis of brain activity, similar to large, cumbersome setups in neuroimaging that are available only in most traditional hospital settings.
By Application
Stroke diagnosis was the largest in terms of brain imaging devices market share in 2024, comprising 29.3% share, due to the increasing global burden of stroke incidences, and the demand for swift diagnosis imaging without invasion, with MRI and CT technology. It is an emergency department that gives top priority to stroke imaging, as timing in treating a stroke is everything. Epilepsy monitoring was the fastest-growing application segment, driven by growing awareness, prevalence, and utilization of continuous EEG and MEG to monitor or track seizures, particularly in children and treatment-resistant patient populations. Advances in long-term wearable EEG and home-based diagnostics are helping make epilepsy detection more efficient and scalable and are accelerating the growth of this segment, as clinicians look for real-time, ambulatory monitoring solutions.
By End-user
Hospitals continued to be the major end-user in 2024, with a market share of 54.6%. Since they have integrated diagnostic systems and specialized neurology departments and receive funding for advanced imaging platforms, they are frequent users of brain imaging equipment. They also manage the highest number of critical neurological conditions, including stroke, traumatic brain injury, and tumors. Diagnostic imaging centers, meanwhile, are the fastest-growing category by end-user. These centers are furnished with high-quality and cost-effective neuroimaging equipment, and they have an expanding outpatient profile. Imaging centers are venturing into new areas in decentralization and rapid diagnosis in response to incentive reimbursement programs and are providing competition to hospital-based imaging and serving the growing need for neurological screening and follow-up.
Regional Analysis:
North America held a significant share of the brain imaging devices market analysis in 2024, owing to high healthcare spending, early adoption of advanced imaging technologies, and favorable reimbursement schemes. The market has been receiving robust R&D investment and significant deployment of AI in the diagnostic imaging sector in the region.
The U.S. brain imaging devices market size was valued at USD 1.80 billion in 2024 and is expected to reach USD 3.28 billion by 2032, growing at a CAGR of 7.78% over 2025-2032. Of the total, the U.S. is a top contender due to a high incidence of neurological diseases, including more than 6 million Americans who have Alzheimer's, and advanced infrastructure. In addition, a number of brain imaging devices have been approved by the U.S. FDA in the last few years, facilitating early uptake. Canada is also seeing increasing demand, mostly reflecting its growing elderly population and investment in neuroscience research. The market continues to be at the lead with the existence of major players and continued public-private partnerships in North America.
Europe is the second-largest brain imaging devices market, supported by well-established government healthcare systems, a high level of neurological screening programs, and increasing uptake of AI-embedded imaging devices. It is a powerhouse of clinical trials and medical technology innovation. Germany dominated in Europe with its sophisticated hospital system, vast diagnostic imaging network, and high level of expenditure on healthcare technologies, and thus was valued at about 24% of the European market in 2024. France and the U.K. are also highly adopting, particularly for stroke diagnosis and epilepsy monitoring. Poland and Russia, meanwhile, are growing fastest in Eastern Europe, due to the modernization of diagnostic facilities and state-sponsored funding initiatives. The EC digital health strategy and the use of AI in diagnostics continue to drive the brain imaging devices market growth in the region.
Asia Pacific is the fastest-growing region in the brain imaging devices market trends due to the increasing burden of neurological diseases, healthcare expenditure, and growing diagnostic infrastructure. China takes the lead in the region, driven by fast hospital expansion, increasing stroke incidence (where stroke is already the major cause of death), and on-site manufacturing of imaging systems. In 2024, China has a market share of around 36% in the Asia Pacific. India is coming up, and portability of EEG and MRI is being used in tier-2 cities and also in rural diagnostics. There is also consistent demand for advanced neuroimaging in Japan, where an aging population and tech-driven health care ecosystem are increasingly using such studies. As AI-enabled diagnostics gain governmental support and private investment, adoption is on the rise in ASEAN countries, South Korea, and Australia, establishing the Asia Pacific (APAC) as the next lucrative region for growth.
Key Players:
Notable brain imaging device companies in the market include GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic, Compumedics Limited, MEGIN, CTF MEG Neuro Innovations Inc., FieldLine Inc., Cerca Magnetics Limited, Advanced Brain Monitoring Inc., Canon Medical Systems Corporation, Natus Medical Incorporated, Magstim EGI, Cadwell Industries Inc., Nihon Kohden Corporation, NeuroLogica Corp., Hitachi High-Tech Corporation, EB Neuro S.p.A., Shimadzu Corporation, and Canon Medical Informatics Inc.
Recent Developments:
In May 2025, Hyperfine secured FDA 510(k) clearance for Optive AI, next-generation AI software integrated into its Swoop portable ultra-low-field MRI system. This release significantly enhances anatomical clarity and diagnostic confidence in decentralized brain MRI imaging.
In July 2024, Positrigo received FDA clearance for its NeuroLF, the first ultra-compact dedicated brain PET system in the U.S., specially designed for functional neuroimaging in Alzheimer’s, epilepsy, Parkinson’s, and tumor diagnostics, boosting accessibility to PET-based advanced brain diagnostics.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 5.68 billion |
| Market Size by 2032 | USD 10.66 billion |
| CAGR | CAGR of 8.21% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Imaging Devices (Electroencephalography (EEG), Magnetoencephalography (MEG), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Other Imaging Devices (Near-Infrared Spectroscopy (NIRS), Single Photon Emission Computed Tomography (SPECT), etc.)), Accessories (Electrodes, Sensors, Other Accessories (Lead wires and caps, Imaging-compatible head restraints, etc.)) • By Modality (Fixed Brain Imaging Devices, Portable Brain Imaging Devices, Wearable Brain Imaging Devices) • By Application (Stroke Diagnosis, Brain Tumor Detection, Traumatic Brain Injury (TBI), Epilepsy Monitoring, Sleep Apnea Assessment, Headache Evaluation, Structural Brain Anomalies, Other Neurological Applications (Alzheimer’s Disease and other dementias, Parkinson’s Disease, etc.)) By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Other Healthcare Settings (Academic & Research Institutions, Neuroscience Research Labs)) |
| Regional Analysis/Coverage | North America (U.S., Canada), Europe (Germany, France, UK, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America) |
| Company Profiles | GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Medtronic, Compumedics Limited, MEGIN, CTF MEG Neuro Innovations Inc., FieldLine Inc., Cerca Magnetics Limited, Advanced Brain Monitoring Inc., Canon Medical Systems Corporation, Natus Medical Incorporated, Magstim EGI, Cadwell Industries Inc., Nihon Kohden Corporation, NeuroLogica Corp., Hitachi High-Tech Corporation, EB Neuro S.p.A., Shimadzu Corporation, and Canon Medical Informatics Inc. |
Ans: Major players include GE HealthCare, Siemens Healthineers, Philips, Medtronic, Canon Medical, and Nihon Kohden, offering a wide range of advanced brain imaging technologies.
Ans: AI enhances diagnostic accuracy, speeds up image analysis, and enables predictive analytics, driving rapid adoption across MRI, EEG, and CT-based neuroimaging platforms.
Ans: Rising prevalence of conditions like stroke, epilepsy, Alzheimer's, and brain tumors significantly increases the need for early and accurate neuroimaging diagnostics.
Ans: Asia-Pacific is the fastest-growing region due to increasing healthcare investment and neurology infrastructure, followed by Latin America with expanding diagnostic access.
Ans: FDA and CE mark approvals impact time-to-market and innovation cycles, while reimbursement frameworks influence device adoption across care settings.
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product Type
2.3.2 Market Size By Modality
2.3.3 Market Size By Application
2.3.4 Market Size By End-User
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/Program Durations
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Reimbursement & Coverage Trends
4.1.1 Country-wise Payer Coverage Analysis
4.1.2 Cost-Effectiveness and Health Technology Assessment (HTA) Trends
4.2 R&D Investment and Funding Trends
4.2.1 Venture Capital and IPO Activity (2020–2024)
4.2.2 Public-Private and Regulatory-Backed Initiatives
4.3 Technology Integration Trends
4.3.1 AI and Predictive Analytics in Brain Imaging
4.3.2 Cloud-Based Platforms and Interoperability in Imaging
4.4 Clinical Research and Innovation Metrics
4.4.1 Brain Imaging Trials by Modality and Indication
4.4.2 Patient Access and Trial Enrollment Trends
4.5 Imaging Utilization and Penetration Rates
4.5.1 Advanced Imaging Adoption in Neurological Diagnosis
4.5.2 Imaging Penetration by Care Setting
5. Brain Imaging Devices Market Segmental Analysis & Forecast, By Product Type, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Imaging Devices
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.2.3 Electroencephalography (EEG)
5.2.3.1 Key Trends
5.2.3.2 Market Size & Forecast, 2021 – 2032
5.2.4 Magnetoencephalography (MEG)
5.2.4.1 Key Trends
5.2.4.2 Market Size & Forecast, 2021 – 2032
5.2.5 Magnetic Resonance Imaging (MRI)
5.2.5.1 Key Trends
5.2.5.2 Market Size & Forecast, 2021 – 2032
5.2.6 Computed Tomography (CT)
5.2.6.1 Key Trends
5.2.6.2 Market Size & Forecast, 2021 – 2032
5.2.7 Positron Emission Tomography (PET)
5.2.7.1 Key Trends
5.2.7.2 Market Size & Forecast, 2021 – 2032
5.2.8 Other Imaging Devices (Near-Infrared Spectroscopy (NIRS), Single Photon Emission Computed Tomography (SPECT), etc.)
5.2.8.1 Key Trends
5.2.8.2 Market Size & Forecast, 2021 – 2032
5.3 Accessories
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.3.3 Accessories
5.3.3.1 Key Trends
5.3.3.2 Market Size & Forecast, 2021 – 2032
5.3.4 Electrodes
5.3.4.1 Key Trends
5.3.4.2 Market Size & Forecast, 2021 – 2032
5.3.5 Sensors
5.3.5.1 Key Trends
5.3.5.2 Market Size & Forecast, 2021 – 2032
5.3.6 Other Accessories (Lead wires and caps, Imaging-compatible head restraints, etc.)
5.3.6.1 Key Trends
5.3.6.2 Market Size & Forecast, 2021 – 2032
6. Brain Imaging Devices Market Segmental Analysis & Forecast, By Modality, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Fixed Brain Imaging Devices
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Portable Brain Imaging Devices
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Wearable Brain Imaging Devices
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Brain Imaging Devices Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Stroke Diagnosis
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Brain Tumor Detection
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Traumatic Brain Injury (TBI)
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.6 Epilepsy Monitoring
7.6.1 Key Trends
7.6.2 Market Size & Forecast, 2021 – 2032
7.7 Sleep Apnea Assessment
7.7.1 Key Trends
7.7.2 Market Size & Forecast, 2021 – 2032
7.8 Headache Evaluation
7.8.1 Key Trends
7.8.2 Market Size & Forecast, 2021 – 2032
7.9 Structural Brain Anomalies
7.9.1 Key Trends
7.9.2 Market Size & Forecast, 2021 – 2032
7.10 Other Neurological Applications (Alzheimer’s Disease and other dementias, Parkinson’s Disease, etc.)
7.10.1 Key Trends
7.10.2 Market Size & Forecast, 2021 – 2032
8. Brain Imaging Devices Market Segmental Analysis & Forecast, By End-User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Diagnostic Imaging Centers
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Ambulatory Surgical Centers (ASCs)
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Specialty Clinics
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
8.6 Other Healthcare Settings (Academic & Research Institutions, Neuroscience Research Labs)
8.6.1 Key Trends
8.6.2 Market Size & Forecast, 2021 – 2032
9. Brain Imaging Devices Market Segmental Analysis & Forecast By Region, 2021 – 2032, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.2.3 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.2.4 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.2.5 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.2.6 Brain Imaging Devices Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.2.6.1.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.2.6.1.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.2.6.1.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.2.6.2.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.2.6.2.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.2.6.2.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.3 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.4 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.5 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6 Brain Imaging Devices Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.1.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.1.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.1.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.2.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.2.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.2.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.3.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.3.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.3.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.4.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.4.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.4.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.5.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.5.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.5.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.6.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.6.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.6.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.7.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.7.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.7.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.3.6.8.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.3.6.8.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.3.6.8.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.3 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.4 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.5 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6 Brain Imaging Devices Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.1.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.1.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.1.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.2.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.2.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.2.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.3.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.3.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.3.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.4.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.4.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.4.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.5.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.5.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.5.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.6.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.6.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.6.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.4.6.7.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.4.6.7.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.4.6.7.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.5.3 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.5.4 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.5 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.5.6 Brain Imaging Devices Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.1.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.1.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.1.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.2.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.2.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.2.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.3.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.3.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.3.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.4.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.4.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.4.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.5.6.5.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.5.6.5.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.5.6.5.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.3 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.4 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.5 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6.6 Brain Imaging Devices Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.1.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.1.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.1.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.2.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.2.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.2.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.3.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.3.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.3.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.4.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.4.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.4.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.5.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.5.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.5.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Brain Imaging Devices Market Size & Forecast, By Product Type, 2021 – 2032
9.6.6.6.2 Brain Imaging Devices Market Size & Forecast, By Modality, 2021 – 2032
9.6.6.6.3 Brain Imaging Devices Market Size & Forecast, By Application, 2021 – 2032
9.6.6.6.4 Brain Imaging Devices Market Size & Forecast, By End-User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number of Strategies Adopted by Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 GE HealthCare Technologies Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Siemens Healthineers AG
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Koninklijke Philips N.V.
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Medtronic
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Compumedics Limited
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 MEGIN
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 CTF MEG Neuro Innovations Inc.
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 FieldLine Inc.
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Cerca Magnetics Limited
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Advanced Brain Monitoring Inc.
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Canon Medical Systems Corporation
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Natus Medical Incorporated
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Magstim EGI
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Cadwell Industries Inc.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Nihon Kohden Corporation
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 NeuroLogica Corp.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Hitachi High-Tech Corporation
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 EB Neuro S.p.A.
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Shimadzu Corporation
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 Canon Medical Informatics Inc.
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product Type
By Modality
By Application
By End-User
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
Europe
Asia Pacific
Middle East & Africa
Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report: